Is adalimumab protective in ischemia-reperfusion injury in lung?

OBJECTIVE(S): Increasing cytokines and reactive oxygen species (ROS) during ischemia reperfusion (I-R) leads to the lung damage. Adalimumab (Ada) is a potent tumor necrosis factor-alpha (TNF-α) inhibitor agent. We aimed to evaluate whether Ada would prevent the lung tissue from damage development ov...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Iran J Basic Med Sci
Main Authors: Kurt, Aysel, Tumkaya, Levent, Kalkan, Yildiray, Turut, Hasan, Cure, Medine Cumhur, Cure, Erkan, Sehitoglu, Ibrahim, Bilgin, Hacer, Usta, Mustafa
Formato: Artigo
Idioma:Inglês
Publicado em: Mashhad University of Medical Sciences 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4764110/
https://ncbi.nlm.nih.gov/pubmed/26949496
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados